JENNIFER PLUMLEY: Open Payments
NPI 1255673042 · LEXINGTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$517 in 32 payments from 12 companies in 2025. Trend: 2023 $317 · 2024 $722 · 2025 $517
Food & beverage: $517
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $138 |
| PFIZER INC. | 4 | $84 |
| AstraZeneca Pharmaceuticals LP | 4 | $74 |
| Amgen Inc. | 3 | $50 |
| Novo Nordisk Inc | 2 | $37 |
| Lilly USA, LLC | 2 | $31 |
| Astellas Pharma US Inc | 1 | $20 |
| Lundbeck LLC | 1 | $20 |
| Amneal Pharmaceuticals LLC | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
Products named: QULIPTA, NURTEC ODT, EVENITY, UBRELVY, BREZTRI, MOUNJARO, FARXIGA, Veozah.
Industry payments across VA — which companies pay providers there.
